Connect
MJA
MJA

Non‐invasive prenatal testing: clinical utility and ethical concerns about recent advances

Helen G Liley, Michael J Peek and James Daly
Med J Aust 2021; 215 (8): . || doi: 10.5694/mja2.51283
Published online: 18 October 2021

To the Editor: Thomas and colleagues1 describe the ethical complexities that can arise in the use of non‐invasive prenatal testing (NIPT) based on the detection of cell‐free fetal DNA in the maternal circulation to screen for chromosomal and other genetic fetal conditions, especially if the clinical utility and implications of the testing are not well understood and explained. They indicate that “the current NIPT tests available are for specific chromosomal aneuploidy, extended panels of targeted conditions and low resolution whole genome sequencing”.

  • Helen G Liley1,2
  • Michael J Peek3
  • James Daly4

  • 1 University of Queensland, Brisbane, QLD
  • 2 Mater Hospital Brisbane, Brisbane, QLD
  • 3 Australian National University, Canberra, ACT
  • 4 Australian Red Cross Lifeblood, Brisbane, QLD


Correspondence: helen.liley@mater.org.au

Competing interests:

No relevant disclosures.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.